Role of hydrophobic substituents on the terminal nitrogen of histamine in receptor binding and agonist activity: development of an orally active histamine type 3 receptor agonist and evaluation of its antistress activity in mice.

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Journal of Medicinal Chemistry

• Publication date

  2010-05-13

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1021/jm901890sPMID 20384344
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• An improved synthesis of 4‐imidazoleëthanol

  2010cited by this paper
• Anxiolytic-like profiles of histamine H3 receptor agonists in animal models of anxiety: a comparative study with antidepressants and benzodiazepine anxiolytic

  2009cited by this paper
• An inverse agonist of the histamine H(3) receptor improves wakefulness in narcolepsy: studies in orexin-/- mice and patients.

  2008cited by this paper
• 4-benzyl-1H-imidazoles with oxazoline termini as histamine H3 receptor agonists.

  2008cited by this paper
• Histamine H3 receptor ligands break ground in a remarkable plethora of therapeutic areas

  2007cited by this paper
• GSK189254, a Novel H3 Receptor Antagonist That Binds to Histamine H3 Receptors in Alzheimer's Disease Brain and Improves Cognitive Performance in Preclinical Models

  2007cited by this paper
• High-Affinity CRF1 Receptor Antagonist NBI-34041: Preclinical and Clinical Data Suggest Safety and Efficacy in Attenuating Elevated Stress Response

  2007cited by this paper
• Desensitization of 5-HT2A receptor function by chronic administration of selective serotonin reuptake inhibitors.

  2006cited by this paper
• A chemical switch for the modulation of the functional activity of higher homologues of histamine on the human histamine H3 receptor: effect of various substitutions at the primary amino function.

  2006cited by this paper
• Nalpha-methyl histamine safety and efficacy in migraine prophylaxis: phase III study.

  2006cited by this paper
• The corticotropin-releasing factor receptor: a novel target for the treatment of depression and anxiety-related disorders

  2005cited by this paper
• Can stress cause depression?

  2005cited by this paper
• The histamine H4 receptor as a new therapeutic target for inflammation.

  2005cited by this paper
• The histamine H3 receptor: from gene cloning to H3 receptor drugs

  2005cited by this paper
• Pharmacological Properties of ABT-239 [4-(2-{2-[(2R)-2-Methylpyrrolidinyl]ethyl}-benzofuran-5-yl)benzonitrile]: I. Potent and Selective Histamine H3 Receptor Antagonist with Drug-Like Properties

  2005cited by this paper
• Pharmacological Properties of ABT-239 [4-(2-{2-[(2R)-2-Methylpyrrolidinyl]ethyl}-benzofuran-5-yl)benzonitrile]: II. Neurophysiological Characterization and Broad Preclinical Efficacy in Cognition and Schizophrenia of a Potent and Selective Histamine H3 Receptor Antagonist

  2005cited by this paper
• Imidazole derivatives as new potent and selective 20-HETE synthase inhibitors.

  2004cited by this paper
• Meta-substituted aryl(thio)ethers as potent partial agonists (or antagonists) for the histamine H3 receptor lacking a nitrogen atom in the side chain.

  2004cited by this paper
• Cyclopropane-based conformational restriction of histamine. (1S,2S)-2-(2-aminoethyl)-1-(1H-imidazol-4-yl)cyclopropane, a highly selective agonist for the histamine H3 receptor, having a cis-cyclopropane structure.

  2003cited by this paper
• Constitutive activity of histamine h(3) receptors stably expressed in SK-N-MC cells: display of agonism and inverse agonism by H(3) antagonists.

  2001cited by this paper
• Comparison of human, mouse, rat, and guinea pig histamine H4 receptors reveals substantial pharmacological species variation.

  2001cited by this paper
• Food-deprived activity stress decreased the activity of the histaminergic neuron system in rats.

  2001cited by this paper
• Species-related pharmacological heterogeneity of histamine H(3) receptors.

  2001cited by this paper
• Genomic organization and characterization of splice variants of the human histamine H3 receptor.

  2001cited by this paper
• High constitutive activity of native H3 receptors regulates histamine neurons in brain

  2000cited by this paper
• Effects of selected histamine H3 receptor antagonists on tele-methylhistamine levels in rat cerebral cortex.

  1999cited by this paper
• Novel partial agonists for the histamine H(3) receptor with high in vitro and in vivo activity.

  1999cited by this paper
• Cloning and functional expression of the human histamine H3 receptor.

  1999cited by this paper
• Neuronal histamine and expression of corticotropin-releasing hormone, vasopressin and oxytocin in the hypothalamus: relative importance of H1 and H2 receptors.

  1998cited by this paper
• Bioavailability, antinociceptive and antiinflammatory properties of BP 2-94, a histamine H3 receptor agonist prodrug.

  1997cited by this paper
• Sleep and Waking during Acute Histamine H3 Agonist BP 2.94 or H3 Antagonist Carboperamide (MR 16155) Administration in Rats

  1996cited by this paper
• N-methyl-d-aspartate (NMDA)-stimulated noradrenaline (NA) release in rat brain cortex is modulated by presynaptic H3-receptors

  1994cited by this paper
• Isolation-induced aggression in mice: effects of 5-hydroxytryptamine uptake inhibitors and involvement of postsynaptic 5-HT1A receptors.

  1994cited by this paper
• S-[2-(4-imidazolyl)ethyl]isothiourea, a highly specific and potent histamine H3 receptor agonist.

  1992cited by this paper
• Histamine H3-receptor activation inhibits acetylcholine release from the guinea pig myenteric plexus

  1991cited by this paper
• Is monoamine turnover in the brain regulated by histamine H3 receptors?

  1990cited by this paper
• Auto-inhibition of brain histamine release mediated by a novel class (H3) of histamine receptor

  1983cited by this paper
• An improved GCMS method to measure tele-methylhistamine.

  1981cited by this paper

• 4-(3-Aminoazetidin-1-yl)pyrimidin-2-amines as High-Affinity Non-imidazole Histamine H3 Receptor Agonists with in Vivo Central Nervous System Activity

  2019cites this paper
• International Union of Basic and Clinical Pharmacology. XCVIII. Histamine Receptors

  2015influential citation
• Synthesis, Crystal Structure and Antitumor Activity of a New 3H-Phenanthro-[2,1-d]imidazole Derivative of Dehydroabietic Acid

  2015cites this paper
• Comprehensive Review in Current Developments of Imidazole‐Based Medicinal Chemistry

  2014cites this paper
• Synthesis and structure-activity relationships of N-aryl-piperidine derivatives as potent (partial) agonists for human histamine H3 receptor.

  2010cites this paper
• Investigation of the histamine H3 receptor binding site. Design and synthesis of hybrid agonists with a lipophilic side chain.

  2010cites this paper